{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:59:33Z","timestamp":1757624373496,"version":"3.44.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1212060063"],"award-info":[{"award-number":["2023B1212060063"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Community-acquired pneumonia (CAP) is a severe respiratory infection that can lead to a range of health issues. Yinma Jiedu (YMJD) granules, a representative classic traditional Chinese patent medicine, are widely used in China, yet high-quality evidence regarding their efficacy in alleviating clinical symptoms remains limited. This study aims to evaluate the efficacy and safety of YMJD granules for the treatment of CAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This multicenter, randomized, double-blind, placebo-controlled parallel clinical trial will be conducted at 11 hospitals in China, with each center enrolling patients competitively. A total of 226 CAP patients who meet the inclusion criteria will be stratified by age and then randomized in a 1:1 ratio to the intervention group (<jats:italic>n<\/jats:italic>\u202f=\u202f113; YMJD granules) or control group (<jats:italic>n<\/jats:italic>\u202f=\u202f113; YMJD placebo). All patients will receive a 7-day treatment course followed by a 7-day follow-up for assessment. The primary outcome is the clinical symptom improvement rate on day 4. Secondary outcomes include the clinical cure rate, the improvement rate of individual symptoms, the Cough and Sputum Assessment Questionnaire, the improved pneumonia imaging absorption evaluation scale, the CURB-65 score, the dosage and course of antibiotics, the changes in inflammatory markers, Traditional Chinese Medicine (TCM) syndrome scores and the amount of emergency drug used. Adverse events will also be assessed. Subgroup analyses will explore heterogeneity in YMJD treatment effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This trial is the first large-sample, randomized, double-blinded, placebo-controlled study of YMJD granules in patients for CAP. It aims to elucidate the mechanisms of early symptoms improvement, identify optimal patient populations, and informing new therapeutic strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>This study design was approved by the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (Reference Number: BF2022-306-01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:uri>https:\/\/www.chictr.org.cn\/showproj.html?proj=189230<\/jats:uri>, Identifier ChiCTR2300072343.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1612945","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:14:21Z","timestamp":1757420061000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Yinma Jiedu granules combined with antibacterial drugs for patients with community-acquired pneumonia: protocol for a multicenter, randomized, double-blind, placebo-parallel controlled clinical trial"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuewei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luoqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihe","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinshu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1016\/j.vaccine.2020.11.004","article-title":"Incidence of community-acquired pneumonia in urban China: a national population-based study","volume":"38","author":"Sun","year":"2020","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijantimicag.2011.02.017","article-title":"Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region","volume":"38","author":"Song","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"ref5","first-page":"1584","volume-title":"Activity of solithromycin and comparators against streptococci isolated from respiratory samples collected in 2012\u201313: 24th European congress of clinical microbiology and infectious diseases","author":"Morrissey","year":"2014"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/joim.13597","article-title":"Clostridium difficile and other adverse events from overprescribed antibiotics for acute upper respiratory infection","volume":"293","author":"Carmichael","year":"2023","journal-title":"J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S0924-8579(09)70013-5","article-title":"Clostridium difficile and fluoroquinolones: is there a link?","volume":"33","author":"Weiss","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jama.2015.3858","article-title":"Empirical therapy of community-acquired pneumonia: advancing evidence or just more doubt?","volume":"314","author":"Mandell","year":"2015","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.13288\/j.11-2166\/r.2019.04.019","article-title":"Guidelines for traditional Chinese medicine diagnosis and treatment of community acquired pneumonia (2018 revision)","volume":"60","author":"Xueqing","year":"2019","journal-title":"J Tradit Chin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"j2471","DOI":"10.1136\/bmj.j2471","article-title":"Advances in the causes and management of community acquired pneumonia in adults","volume":"358","author":"Wunderink","year":"2017","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jama.2024.14796","article-title":"Community-acquired pneumonia: a review","volume":"332","author":"Vaughn","year":"2024","journal-title":"JAMA"},{"key":"ref14","first-page":"91","article-title":"Effects of Yinma Jiedu granules on lung function and expression of inflammatory factors in children with acute bronchitis syndrome of phlegm-heat obstructing lung","volume":"19","author":"Wei","year":"2022","journal-title":"Med Innov China"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.16281\/j.cnki.jocml.2018.33.007","article-title":"Clinical observation on Yinma Jiedu granule combined with western medicine in treating acute exacerbation of chronic obstructive pulmonary disease","volume":"5","author":"Pei-quan","year":"2018","journal-title":"Electron J Clin Med Lit"},{"key":"ref16","first-page":"33","article-title":"Experiment of bacteriostatic activities in vitro in water-decocted liquid of portulaca oleracea L.and houttuynia cordata thunb","volume":"7","author":"Xiao-he","year":"2010","journal-title":"Anti-Infect Pharm"},{"key":"ref17","first-page":"298","article-title":"Extract of ingredients for medicine in lonicera confusa DC and study on antibiotic activity","volume":"40","author":"Lan","year":"2012","journal-title":"Med Sci J Cent South China"},{"key":"ref18","first-page":"151","article-title":"Antibacterial activity of extacts from Plantago asiatica L","volume":"29","author":"Yang","year":"2010","journal-title":"China Brew"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.13286\/j.cnki.chinhosppharmacyj.2017.20.08","article-title":"Antibacterial efftects in vitro of Yinma Jiedu granules combined with antibiotics","volume":"37","author":"Rui","year":"2017","journal-title":"Chin J Hosp Pharm"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3760\/cma.j.issn.1001-0939.2016.04.005","article-title":"Guideline of diagnosis and treatment for community acquired pneumonia among adults in China (released in 2016)","volume":"39","year":"2016","journal-title":"Chin J Tuberc Respir"},{"key":"ref21","volume-title":"Clinic terminology of traditional Chinese medical diagnosis and treatment-Part 2:Syndromes\/patterns[S]. 2021-11-26","year":"2021"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.chest.2021.10.031","article-title":"Pneumonia severity index and CURB-65 score are good predictors of mortality in hospitalized patients with SARS-CoV-2 community-acquired pneumonia","volume":"161","author":"Bradley","year":"2022","journal-title":"Chest"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.3748\/wjg.v26.i28.4170","article-title":"Epigastric pain syndrome: what can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong granules","volume":"26","author":"Wen","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1473-3099(16)00017-7","article-title":"Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)","volume":"16","author":"Barrera","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa1800201","article-title":"Omadacycline for community-acquired bacterial pneumonia","volume":"380","author":"Stets","year":"2019","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.rmed.2008.06.009","article-title":"Development and validation of a cough and sputum assessment questionnaire","volume":"102","author":"Crawford","year":"2008","journal-title":"Respir Med"},{"key":"ref27","first-page":"185","article-title":"Preliminary development and application of pneumonia chest film absorption evaluation scale","volume":"11","author":"Yin","year":"2012","journal-title":"Chin J Respir Crit Care Med"},{"key":"ref28","volume-title":"Adult Community Acuired Pneumonia Audit 2018\u20132019, reports Vol 10, Issue 4","year":"2019"},{"key":"ref29","first-page":"121","article-title":"A clinical study on the treatment of community acquired pneumonia with the \"real world\" method of strengthening and detoxifying virtues","volume":"31","author":"Feng","year":"2020","journal-title":"Lishizhen Med Mater Med Res"},{"key":"ref30","first-page":"13","article-title":"Chinese national guideline on diagnosis and management of cough (2021)","volume":"45","year":"2022","journal-title":"Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi"},{"key":"ref31","first-page":"1486","article-title":"Cytokine changes in community-acquired pneumonia in elderly and intervention of traditional Chinese medicine","volume":"35","author":"Ye","year":"2010","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"ref32","first-page":"113","article-title":"Application of professor Zhou Zhongying's theory of stasis-heat to pulmonary diseases: insights from clinical evidence","volume":"11","author":"Suofang","year":"2013","journal-title":"Chin Med Mod Distance Educ China"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"101297","DOI":"10.1016\/j.ctcp.2020.101297","article-title":"Efficacy and safety of yinqiao powder combined with western medicine in the treatment of pneumonia: a systematic review and meta-analysis","volume":"42","author":"Fan","year":"2021","journal-title":"Complement Ther Clin Pract"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/jcpt.13706","article-title":"Efficacy and safety of Tanreqing injection combined with antibiotics against Streptococcus pneumoniae pneumonia: a systematic review and meta-analysis","volume":"47","author":"Li","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e735","DOI":"10.1097\/CCM.0000000000003842","article-title":"Xue bijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial","volume":"47","author":"Song","year":"2019","journal-title":"Crit Care Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.16841\/j.issn1003-8450.2023.06.11","article-title":"Clinical observation on 31 cases of community-acquired pneumonia with wind-heat invading lung treated by Yinma Jiedu Keli as adjuvant therapy","volume":"40","author":"Zhao","year":"2023","journal-title":"J Gansu Univ Chin Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e00635","DOI":"10.1128\/AAC.00635-18","article-title":"Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults","volume":"62","author":"Tansarli","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1056\/NEJMcp2303286","article-title":"Community-acquired pneumonia","volume":"389","author":"File","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1612945\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:30:28Z","timestamp":1757421028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1612945\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":38,"alternative-id":["10.3389\/fmed.2025.1612945"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1612945","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"article-number":"1612945"}}